Contract Manufacturing
Advanced CDMO services from startup to scale with capacities from 1L to >3000L and services from formulation to finishing.
Learn MoreInnovative Solutions
From concept to final project. Deploying market-leading CDMO-technology to bring your solutions to scale.
Medical Devices
In-house development and production of advanced medical devices and technologies to facilitate patient care and improve quality of life.
Learn MoreCovid-19 Pandemic Response
Employing advanced American manufacturing to solve global problems, Attwill has been there every step of the way, from mass-producing isopropyl hand sanitizer, to LyoSphere COVID test kits, to development and manufacture of next-generation COVID vaccines and treatments.
Attwill – American Biomedical Manufacturing and Development
Attwill holds America’s largest medical lyophilization capacity and acts as a vital link in the domestic supply chain for critical healthcare technologies while advancing American-made, next-generation, biomedical manufacturing.
Recent News
June 10, 2021
Attwill welcomes former WI Gov. & Current UW System President Tommy Thompson
Attwill was proud to host former WI governor and current president of the UW System Tommy Thomson for a roundtable discussion to improve ties between the University and UW system.
Read More
June 1, 2021
US. Sen. Tammy Baldwin visits Attwill Medical Solutions
Attwill was proud to host U.S. Senator Tammy Baldwin (D-WI) for a roundtable discussion regarding the manufacturing life science components in the United States.
Read More
February 19, 2021
U.S. Representative Glenn Grothman visits Attwill Medical Solutions for roundtable discussion
Attwill Medical Solutions™ was proud to host U.S. Representative Glenn Grothman for a roundtable discussion regarding the company, as well as a comprehensive facility tour.
Read More
October 2, 2020
Attwill Receives FDA 510k clearance for HaloGUARD™
Attwill Medical Solutions™ is pleased to disclose that its HaloGUARD™ product received FDA 510 (k) clearance in September 2020.
Read More
June 25, 2020
Operation Warp Speed participant, Vaxart, Inc. (NASDAQ: "VXRT"), signs MOU with AMS for production of COVID-19 Vaccine
Vaxart, Inc. has announced it will be working with Attwill Medical Solutions™ to manufacture its revolutionary oral vaccine for COVID-19.
Read More
April 8, 2020
Attwill partners with local distillery to produce hand sanitizer for COVID crisis
Attwill Medical Solutions is partnering with a nearby distillery to produce and sell hand sanitizer to hospitals and essential workers.